Quick summary: SALOFALK 500mg: tablets may show black spots due to the oxidation of the active ingredient.. Date: 2025-04-24.
SALOFALK 500mg: tablets may show black spots due to the oxidation of the active ingredient.
2025-04-24
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: SALOFALK 500mg: tablets may show black spots due to the oxidation of the active ingredient.. Date: 2025-04-24.
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
Some tablets in the affected batches may show black spots due to the oxidation of the active ingredient.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.